LifeSiteNews has been permanently banned on YouTube. Click HERE to sign up to receive emails when we add to our video library.
ANALYSIS
April 1, 2021 (LifeSiteNews) — Less than two months after its conditional marketing authorization by the European Medicines Agency (EMA) at the end of January, the controversial AstraZeneca COVID-19 vaccine was linked last Friday with cases of thrombosis, by the French Drug Agency (ANSM, Agence nationale de sécurité du medicament).
Until that acknowledgement, the official narrative was that thromboses of the type registered after individuals received the AstraZeneca shots were not more frequent than in the general population, or more numerous than expected.
On March 17, the World Health Organization downplayed the issue, patronizingly stating: “Vaccination against COVID-19 will not reduce illness or deaths from other causes. Thromboembolic events are known to occur frequently. Venous thromboembolism is the third most common cardiovascular disease globally.” The WHO did not take into account the specific circumstances that were being reported. And now it appears that the WHO was wrong.
The ANSM’s report was published with data up to March 18, 2021. At that point, with over 1,430,000 AstraZeneca shots injected in France, a total of 5,693 adverse events had been registered
The remainder of this article is available in its entirety at LifeSite News
The views expressed in this news alert by the author do not directly represent that of The Official Street Preachers or its editors